IPHA

Innate Pharma Sa

• NASDAQ·5d ago

  Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA)

• NASDAQ·10/02 11:44

  Innate Pharma S.A. - Depositary Receipt Price Target Increased by 27.91% to $8.22

• TipRanks·10/01 14:36

  H.C. Wainwright Remains a Buy on Innate Pharma (IPHA)

• NASDAQ·09/23 16:00

  Innate Pharma (IPHA) Upgraded to Buy: Here's What You Should Know

• TipRanks·09/21 10:40

  Analysts Offer Insights on Healthcare Companies: Innate Pharma (IPHA) and Alnylam Pharma (ALNY)

• TipRanks·09/18 10:55

  BTIG Remains a Buy on Innate Pharma (IPHA)

• Dow Jones·09/17 16:01

  Innate Pharma Price Target Maintained With a $9.00/Share by BTIG

• Benzinga·09/17 15:51

  BTIG Reiterates Buy on Innate Pharma, Maintains $9 Price Target

• Benzinga·09/17 12:27

  Innate Pharma H1 2026 Earnings Call Transcript

• Benzinga·09/17 11:11

  Earnings Scheduled For September 17, 2026

• Seeking Alpha·09/17 05:19

  Innate Pharma gives H1 results

• Benzinga·09/17 05:12

  Innate Pharma H1 EPS $(0.24) Misses $(0.16) Estimate, Sales $6.583M Miss $9.100M Estimate

• TipRanks·09/16 20:05

  Innate Pharma says previously announced partnership with Sobi now effective

• TipRanks·09/02 10:30

  Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), NRX Pharmaceuticals (NRXP) and Innate Pharma (IPHA)

• Benzinga·08/14 12:06

  12 Health Care Stocks Moving In Friday's Pre-Market Session